Search Within

Ingo K Mellinghoff

  1. "Biostatistics Service"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (8)
  3. Research Letter (2)
  4. Correspondence (1)
Groups
  1. Biostatistics Service (28)
  2. Epidemiology and Biostatistics (28)
  3. GSK Faculty (28)
  4. Human Oncology and Pathogenesis Program (28)
  5. Tow Center for Developmental Oncology (TCDO) (28)
  6. Population Sciences Research Program (23)

More Groups

People
  1. Katherine Panageas (19)
  2. Lisa De Angelis (16)
  3. Thomas Kaley (16)
  4. Anne Reiner (13)
  5. Christian Grommes (13)
  6. Craig Nolan (11)

More People

Years
  1. 2024 (4)
  2. 2023 (2)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (1)
  6. 2019 (4)

More Years

Publications
  1. Neuro-Oncology (8)
  2. Clinical Cancer Research (5)
  3. European Journal of Nuclear Medicine and Molecular Imaging (2)
  4. Journal of Clinical Oncology (2)
  5. American Journal of Neuroradiology (1)
  6. Annals of Clinical and Translational Neurology (1)

More Publications

Publishers
  1. Oxford University Press (8)
  2. American Association for Cancer Research (6)
  3. American Society of Clinical Oncology (3)
  4. Nature Publishing Group (3)
  5. Springer (3)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intermittent high dose (pulsatile) erlotinib for EGFRvIII mutant recurrent malignant gliomas: A pilot clinical trial
    Meeting Abstract

    Lassman, A.; Grommes, C.; Panageas, K.; Iwamoto, F.; DeAngelis, L.; Kaley, T.; Gavrilovic, I.; Pentsova, E.; Omuro, A.; Corpuz, C.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma
    Journal Article

    Omuro, A.; Beal, K.; Gutin, P.; Karimi, S.; Correa, D. D.; Kaley, T. J.; Deangelis, L. M.; Chan, T. A.; Gavrilovic, I. T.; Nolan, C.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
    Journal Article

    Omuro, A.; Chan, T. A.; Abrey, L. E.; Khasraw, M.; Reiner, A. S.; Kaley, T. J.; De Angelis, L. M.; Lassman, A. B.; Nolan, C. P.; Gavrilovic, I. T.; more...
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma
    Journal Article

    Gorovets, D.; Kannan, K.; Shen, R.; Kastenhuber, E. R.; Islamdoust, N.; Campos, C.; Pentsova, E.; Heguy, A.; Jhanwar, S. C.; Mellinghoff, I. K.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M. P.; Beal, K.; Karimi, S.; Correa, D.; Chan, T. A.; DeAngelis, L. M.; Gavrilovic, I. T.; Nolan, C.; Hormigo, A.; Lassman, A. B.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase I trial of temsirolimus and perifosine for recurrent or progressive malignant glioma
    Meeting Abstract

    Lassman, A. B.; Kaley, T. J.; Deangelis, L. M.; Hormigo, A.; Mellinghoff, I. K.; Otap, D. D.; Seger, J.; Doyle, L. A.; Ludwig, E.; Lacouture, M. E.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma
    Meeting Abstract

    Omuro, A.; Beal, K.; Correa, D.; Chan, T.; DeAngelis, L.; Gavrilovic, I.; Nolan, C.; Hormigo, A.; Lassman, A. B.; Kaley, T.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer
    Journal Article

    Regales, L.; Gong, Y.; Shen, R.; de Stanchina, E.; Vivanco, I.; Goel, A.; Koutcher, J. A.; Spassova, M.; Ouerfelli, O.; Mellinghoff, I. K.; more...
    Journal of Clinical Investigation (2009)

    Fulltext@MSK | Save